Tirzepatide
Clinical trials for Tirzepatide explained in plain language.
Never miss a new study
Get alerted when new Tirzepatide trials appear
Sign up with your email to follow new studies for Tirzepatide, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a diabetes drug help heart failure patients walk farther?
Disease control Not yet recruitingThis trial tests whether tirzepatide, a weekly injection used for diabetes and weight loss, can improve physical function in adults with heart failure and obesity. Participants will receive either tirzepatide or a placebo for six months, while continuing their usual heart failure…
Matched conditions: TIRZEPATIDE
Phase 3 • Sponsor: Shahid Beheshti University of Medical Sciences • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Weight-Loss drug mounjaro could keep hearts in rhythm after ablation
Disease control Not yet recruitingThis study tests whether the diabetes and weight-loss drug tirzepatide (Mounjaro) can reduce the chance of atrial fibrillation coming back after a heart procedure called catheter ablation. About 602 adults with obesity and a type of heart failure (HFpEF) will get either tirzepati…
Matched conditions: TIRZEPATIDE
Phase 4 • Sponsor: Yunlong Wang • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Dual glucose-dependent insulinotropic peptide (GIP) and glucagon-like Peptide-1 (GLP-1) receptor agonist in women with obesity for frozen embryo transfer (FET): pragmatic, multicenter, randomized controlled trial
Not yet recruitingTo evaluate the efficacy and safety of Dual GIP/GLP-1 receptor agonist pretreatment on reproductive outcomes in obese women before frozen embryo transfer.
Matched conditions: TIRZEPATIDE
Sponsor: RenJi Hospital
Last updated Sep 10, 2026 17:00 UTC